Holding types
Countries
Sectors
Analyst ratings
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Pharma ETFs in Focus Post Solid Q2 Earnings
FTXH
zacks.com14 August 2024
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
JNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focus
FTXH
Zacks Investment Research17 April 2024
Johnson & Johnson (JNJ) maintained its trend of surpassing earnings expectations but fell short of revenue projections.
Pharma ETFs in Focus Post Q3 Earnings
FTXH
Zacks Investment Research08 November 2023
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
Pharma ETFs Gain Post Q1 Earnings
FTXH
Zacks Investment Research09 May 2023
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. As such, pharma ETFs have been in the green over the past month.
FAQ
- What is FTXH ETF?
- Does FTXH pay dividends?
- What stocks are in FTXH ETF?
- What is the current assets under management for FTXH?
- What is FTXH average volume?
- What is FTXH expense ratio?
- What is FTXH inception date?
What is FTXH ETF?
FTXH ETF is an exchange-traded fund that focuses on investing in companies involved in the cryptocurrency and blockchain sectors. It aims to provide investors with exposure to the growing digital asset market while offering diversification and liquidity through a single investment vehicle.
Does FTXH pay dividends?
Yes, the First Trust Nasdaq Pharmaceuticals ETF does pays dividends, with
the most recent payment being
$0.12
per share. The last ex-dividend date was on 26 September 2024, and the next ex-dividend date has not been announced yet
What stocks are in FTXH ETF?
As of today, First Trust Nasdaq Pharmaceuticals ETF inlcudes 51 holdings, with 50 of them being companies from 4 different countries and 1 sectors. The most weighted holdings are Bristol-Myers Squibb (8.88%), Johnson & Johnson (7%) and AbbVie (6.98%)
What is the current assets under management for FTXH?
Assets under management of First Trust Nasdaq Pharmaceuticals ETF is $18 M
What is FTXH average volume?
Average volume of First Trust Nasdaq Pharmaceuticals ETF is $5543
What is FTXH expense ratio?
Expense ratio of First Trust Nasdaq Pharmaceuticals ETF is 0.60%
What is FTXH inception date?
Inception date of First Trust Nasdaq Pharmaceuticals ETF is 22 September 2016